nodes	percent_of_prediction	percent_of_DWPC	metapath
Amoxapine—HTR1B—trigeminal nucleus—multiple sclerosis	0.0605	0.159	CbGeAlD
Amoxapine—HTR3A—area postrema—multiple sclerosis	0.0532	0.139	CbGeAlD
Amoxapine—HTR2A—trigeminal nucleus—multiple sclerosis	0.0291	0.0763	CbGeAlD
Amoxapine—HTR1B—trigeminal nerve—multiple sclerosis	0.0159	0.0417	CbGeAlD
Amoxapine—HTR7—pons—multiple sclerosis	0.00863	0.0226	CbGeAlD
Amoxapine—HTR2A—trigeminal nerve—multiple sclerosis	0.00765	0.02	CbGeAlD
Amoxapine—DRD1—nerve—multiple sclerosis	0.00716	0.0188	CbGeAlD
Amoxapine—HTR3A—nerve—multiple sclerosis	0.00692	0.0181	CbGeAlD
Amoxapine—SLC6A3—nerve—multiple sclerosis	0.00576	0.0151	CbGeAlD
Amoxapine—HTR7—peripheral nervous system—multiple sclerosis	0.00574	0.0151	CbGeAlD
Amoxapine—HTR2A—pons—multiple sclerosis	0.00538	0.0141	CbGeAlD
Amoxapine—SLC6A2—nerve—multiple sclerosis	0.00465	0.0122	CbGeAlD
Amoxapine—HTR7—nerve—multiple sclerosis	0.00448	0.0117	CbGeAlD
Amoxapine—DRD2—nerve—multiple sclerosis	0.00423	0.0111	CbGeAlD
Amoxapine—ADRA2A—peripheral nervous system—multiple sclerosis	0.00421	0.011	CbGeAlD
Amoxapine—HTR2A—pineal body—multiple sclerosis	0.00384	0.0101	CbGeAlD
Amoxapine—HTR2A—peripheral nervous system—multiple sclerosis	0.00358	0.00939	CbGeAlD
Amoxapine—DRD1—brainstem—multiple sclerosis	0.00308	0.00806	CbGeAlD
Amoxapine—HTR3A—brainstem—multiple sclerosis	0.00297	0.00778	CbGeAlD
Amoxapine—HTR2A—nerve—multiple sclerosis	0.00279	0.00732	CbGeAlD
Amoxapine—HTR1B—brainstem—multiple sclerosis	0.00249	0.00653	CbGeAlD
Amoxapine—GABRA1—brainstem—multiple sclerosis	0.00249	0.00653	CbGeAlD
Amoxapine—SLC6A3—brainstem—multiple sclerosis	0.00247	0.00648	CbGeAlD
Amoxapine—DRD4—brain—multiple sclerosis	0.00245	0.00641	CbGeAlD
Amoxapine—HTR2C—brainstem—multiple sclerosis	0.00239	0.00626	CbGeAlD
Amoxapine—SLC6A4—brainstem—multiple sclerosis	0.00227	0.00594	CbGeAlD
Amoxapine—DRD3—nervous system—multiple sclerosis	0.00225	0.0059	CbGeAlD
Amoxapine—DRD3—central nervous system—multiple sclerosis	0.00217	0.00568	CbGeAlD
Amoxapine—HTR6—nervous system—multiple sclerosis	0.00217	0.00568	CbGeAlD
Amoxapine—HTR6—central nervous system—multiple sclerosis	0.00209	0.00547	CbGeAlD
Amoxapine—HTR1A—brainstem—multiple sclerosis	0.00201	0.00527	CbGeAlD
Amoxapine—SLC6A2—brainstem—multiple sclerosis	0.00199	0.00523	CbGeAlD
Amoxapine—DRD1—midbrain—multiple sclerosis	0.00196	0.00514	CbGeAlD
Amoxapine—HTR7—brainstem—multiple sclerosis	0.00192	0.00504	CbGeAlD
Amoxapine—ADRA1A—brainstem—multiple sclerosis	0.00185	0.00486	CbGeAlD
Amoxapine—DRD2—brainstem—multiple sclerosis	0.00182	0.00476	CbGeAlD
Amoxapine—DRD2—retina—multiple sclerosis	0.00175	0.00459	CbGeAlD
Amoxapine—GABRA1—medulla oblongata—multiple sclerosis	0.00174	0.00455	CbGeAlD
Amoxapine—DRD3—brain—multiple sclerosis	0.00172	0.00451	CbGeAlD
Amoxapine—HTR2C—medulla oblongata—multiple sclerosis	0.00167	0.00437	CbGeAlD
Amoxapine—HTR6—brain—multiple sclerosis	0.00166	0.00434	CbGeAlD
Amoxapine—ORM1—spinal cord—multiple sclerosis	0.00165	0.00433	CbGeAlD
Amoxapine—DRD1—nervous system—multiple sclerosis	0.00161	0.00422	CbGeAlD
Amoxapine—HTR1B—midbrain—multiple sclerosis	0.00159	0.00416	CbGeAlD
Amoxapine—GABRA1—midbrain—multiple sclerosis	0.00159	0.00416	CbGeAlD
Amoxapine—SLC6A3—midbrain—multiple sclerosis	0.00158	0.00413	CbGeAlD
Amoxapine—HTR3A—nervous system—multiple sclerosis	0.00156	0.00408	CbGeAlD
Amoxapine—DRD1—central nervous system—multiple sclerosis	0.00155	0.00407	CbGeAlD
Amoxapine—HTR1B—spinal cord—multiple sclerosis	0.00155	0.00406	CbGeAlD
Amoxapine—GABRA1—spinal cord—multiple sclerosis	0.00155	0.00406	CbGeAlD
Amoxapine—SLC6A3—spinal cord—multiple sclerosis	0.00154	0.00403	CbGeAlD
Amoxapine—HTR2C—midbrain—multiple sclerosis	0.00152	0.00399	CbGeAlD
Amoxapine—HTR3A—central nervous system—multiple sclerosis	0.0015	0.00393	CbGeAlD
Amoxapine—HTR2C—spinal cord—multiple sclerosis	0.00149	0.00389	CbGeAlD
Amoxapine—SLC6A4—midbrain—multiple sclerosis	0.00144	0.00378	CbGeAlD
Amoxapine—SLC6A4—spinal cord—multiple sclerosis	0.00141	0.00369	CbGeAlD
Amoxapine—ORM1—nervous system—multiple sclerosis	0.00139	0.00365	CbGeAlD
Amoxapine—SLC6A2—medulla oblongata—multiple sclerosis	0.00139	0.00364	CbGeAlD
Amoxapine—ORM1—central nervous system—multiple sclerosis	0.00134	0.00351	CbGeAlD
Amoxapine—HTR7—medulla oblongata—multiple sclerosis	0.00134	0.00351	CbGeAlD
Amoxapine—HTR1B—nervous system—multiple sclerosis	0.00131	0.00342	CbGeAlD
Amoxapine—GABRA1—nervous system—multiple sclerosis	0.00131	0.00342	CbGeAlD
Amoxapine—SLC6A3—nervous system—multiple sclerosis	0.0013	0.00339	CbGeAlD
Amoxapine—HTR1A—midbrain—multiple sclerosis	0.00128	0.00336	CbGeAlD
Amoxapine—HTR1B—central nervous system—multiple sclerosis	0.00126	0.00329	CbGeAlD
Amoxapine—GABRA1—central nervous system—multiple sclerosis	0.00126	0.00329	CbGeAlD
Amoxapine—HTR2C—nervous system—multiple sclerosis	0.00125	0.00328	CbGeAlD
Amoxapine—HTR1A—spinal cord—multiple sclerosis	0.00125	0.00328	CbGeAlD
Amoxapine—SLC6A3—central nervous system—multiple sclerosis	0.00125	0.00327	CbGeAlD
Amoxapine—DRD1—brain—multiple sclerosis	0.00123	0.00323	CbGeAlD
Amoxapine—GABRA1—cerebellum—multiple sclerosis	0.00123	0.00322	CbGeAlD
Amoxapine—HTR7—midbrain—multiple sclerosis	0.00122	0.00321	CbGeAlD
Amoxapine—SLC6A3—cerebellum—multiple sclerosis	0.00122	0.00319	CbGeAlD
Amoxapine—HTR2C—central nervous system—multiple sclerosis	0.00121	0.00316	CbGeAlD
Amoxapine—HTR2A—brainstem—multiple sclerosis	0.0012	0.00314	CbGeAlD
Amoxapine—HTR7—spinal cord—multiple sclerosis	0.0012	0.00313	CbGeAlD
Amoxapine—HTR3A—brain—multiple sclerosis	0.00119	0.00312	CbGeAlD
Amoxapine—SLC6A4—nervous system—multiple sclerosis	0.00119	0.00311	CbGeAlD
Amoxapine—CHRM1—nervous system—multiple sclerosis	0.00118	0.0031	CbGeAlD
Amoxapine—HTR2B—nervous system—multiple sclerosis	0.00118	0.00308	CbGeAlD
Amoxapine—DRD2—midbrain—multiple sclerosis	0.00116	0.00303	CbGeAlD
Amoxapine—HTR2A—retina—multiple sclerosis	0.00116	0.00303	CbGeAlD
Amoxapine—SLC6A4—central nervous system—multiple sclerosis	0.00114	0.00299	CbGeAlD
Amoxapine—CHRM1—central nervous system—multiple sclerosis	0.00114	0.00298	CbGeAlD
Amoxapine—HTR2B—central nervous system—multiple sclerosis	0.00113	0.00297	CbGeAlD
Amoxapine—CYP2D6—brainstem—multiple sclerosis	0.00109	0.00286	CbGeAlD
Amoxapine—HTR1A—nervous system—multiple sclerosis	0.00105	0.00276	CbGeAlD
Amoxapine—SLC6A2—nervous system—multiple sclerosis	0.00104	0.00274	CbGeAlD
Amoxapine—HTR1A—central nervous system—multiple sclerosis	0.00101	0.00266	CbGeAlD
Amoxapine—HTR7—nervous system—multiple sclerosis	0.00101	0.00264	CbGeAlD
Amoxapine—SLC6A2—central nervous system—multiple sclerosis	0.00101	0.00264	CbGeAlD
Amoxapine—HTR1B—brain—multiple sclerosis	0.000998	0.00262	CbGeAlD
Amoxapine—GABRA1—brain—multiple sclerosis	0.000998	0.00262	CbGeAlD
Amoxapine—HTR1A—cerebellum—multiple sclerosis	0.000992	0.0026	CbGeAlD
Amoxapine—SLC6A3—brain—multiple sclerosis	0.00099	0.00259	CbGeAlD
Amoxapine—ADRA2A—medulla oblongata—multiple sclerosis	0.000983	0.00258	CbGeAlD
Amoxapine—ADRA1A—nervous system—multiple sclerosis	0.000971	0.00255	CbGeAlD
Amoxapine—HTR7—central nervous system—multiple sclerosis	0.000969	0.00254	CbGeAlD
Amoxapine—HTR2C—brain—multiple sclerosis	0.000957	0.00251	CbGeAlD
Amoxapine—DRD2—nervous system—multiple sclerosis	0.000952	0.00249	CbGeAlD
Amoxapine—HTR7—cerebellum—multiple sclerosis	0.000948	0.00248	CbGeAlD
Amoxapine—ADRA1A—central nervous system—multiple sclerosis	0.000935	0.00245	CbGeAlD
Amoxapine—DRD2—central nervous system—multiple sclerosis	0.000917	0.0024	CbGeAlD
Amoxapine—ADRA1A—cerebellum—multiple sclerosis	0.000914	0.0024	CbGeAlD
Amoxapine—SLC6A4—brain—multiple sclerosis	0.000907	0.00238	CbGeAlD
Amoxapine—CHRM1—brain—multiple sclerosis	0.000904	0.00237	CbGeAlD
Amoxapine—HTR2B—brain—multiple sclerosis	0.000899	0.00236	CbGeAlD
Amoxapine—ADRA2A—midbrain—multiple sclerosis	0.000898	0.00235	CbGeAlD
Amoxapine—DRD2—cerebellum—multiple sclerosis	0.000896	0.00235	CbGeAlD
Amoxapine—ADRA2A—spinal cord—multiple sclerosis	0.000876	0.0023	CbGeAlD
Amoxapine—HTR2A—medulla oblongata—multiple sclerosis	0.000836	0.00219	CbGeAlD
Amoxapine—Hallucination—Methylprednisolone—multiple sclerosis	0.000825	0.00253	CcSEcCtD
Amoxapine—Myocardial infarction—Betamethasone—multiple sclerosis	0.000823	0.00253	CcSEcCtD
Amoxapine—Myocardial infarction—Dexamethasone—multiple sclerosis	0.000823	0.00253	CcSEcCtD
Amoxapine—Diarrhoea—Cladribine—multiple sclerosis	0.000815	0.0025	CcSEcCtD
Amoxapine—Cerebrovascular accident—Methotrexate—multiple sclerosis	0.00081	0.00248	CcSEcCtD
Amoxapine—HTR1A—brain—multiple sclerosis	0.000805	0.00211	CbGeAlD
Amoxapine—Pancreatitis—Prednisone—multiple sclerosis	0.000804	0.00247	CcSEcCtD
Amoxapine—SLC6A2—brain—multiple sclerosis	0.000799	0.00209	CbGeAlD
Amoxapine—Feeling abnormal—Azathioprine—multiple sclerosis	0.000798	0.00245	CcSEcCtD
Amoxapine—Gastrointestinal pain—Azathioprine—multiple sclerosis	0.000792	0.00243	CcSEcCtD
Amoxapine—Confusional state—Mitoxantrone—multiple sclerosis	0.000789	0.00242	CcSEcCtD
Amoxapine—Dizziness—Cladribine—multiple sclerosis	0.000787	0.00242	CcSEcCtD
Amoxapine—Oedema—Mitoxantrone—multiple sclerosis	0.000783	0.0024	CcSEcCtD
Amoxapine—Shock—Mitoxantrone—multiple sclerosis	0.00077	0.00236	CcSEcCtD
Amoxapine—HTR7—brain—multiple sclerosis	0.00077	0.00202	CbGeAlD
Amoxapine—Thrombocytopenia—Mitoxantrone—multiple sclerosis	0.000766	0.00235	CcSEcCtD
Amoxapine—Body temperature increased—Azathioprine—multiple sclerosis	0.000765	0.00235	CcSEcCtD
Amoxapine—Abdominal pain—Azathioprine—multiple sclerosis	0.000765	0.00235	CcSEcCtD
Amoxapine—HTR2A—midbrain—multiple sclerosis	0.000764	0.002	CbGeAlD
Amoxapine—Tachycardia—Mitoxantrone—multiple sclerosis	0.000764	0.00234	CcSEcCtD
Amoxapine—Vomiting—Cladribine—multiple sclerosis	0.000757	0.00232	CcSEcCtD
Amoxapine—Erectile dysfunction—Prednisone—multiple sclerosis	0.000756	0.00232	CcSEcCtD
Amoxapine—HRH1—nervous system—multiple sclerosis	0.000752	0.00197	CbGeAlD
Amoxapine—Rash—Cladribine—multiple sclerosis	0.000751	0.0023	CcSEcCtD
Amoxapine—Hallucination—Dexamethasone—multiple sclerosis	0.00075	0.0023	CcSEcCtD
Amoxapine—Hallucination—Betamethasone—multiple sclerosis	0.00075	0.0023	CcSEcCtD
Amoxapine—Dermatitis—Cladribine—multiple sclerosis	0.00075	0.0023	CcSEcCtD
Amoxapine—Weight increased—Prednisone—multiple sclerosis	0.000747	0.00229	CcSEcCtD
Amoxapine—Anorexia—Mitoxantrone—multiple sclerosis	0.000746	0.00229	CcSEcCtD
Amoxapine—Ataxia—Methotrexate—multiple sclerosis	0.000746	0.00229	CcSEcCtD
Amoxapine—Headache—Cladribine—multiple sclerosis	0.000746	0.00229	CcSEcCtD
Amoxapine—HTR2A—spinal cord—multiple sclerosis	0.000745	0.00195	CbGeAlD
Amoxapine—ADRA1A—brain—multiple sclerosis	0.000742	0.00195	CbGeAlD
Amoxapine—Vision blurred—Prednisolone—multiple sclerosis	0.000741	0.00227	CcSEcCtD
Amoxapine—ADRA2A—nervous system—multiple sclerosis	0.000739	0.00194	CbGeAlD
Amoxapine—Hypotension—Mitoxantrone—multiple sclerosis	0.000731	0.00224	CcSEcCtD
Amoxapine—DRD2—brain—multiple sclerosis	0.000728	0.00191	CbGeAlD
Amoxapine—HRH1—central nervous system—multiple sclerosis	0.000724	0.0019	CbGeAlD
Amoxapine—Acute coronary syndrome—Prednisone—multiple sclerosis	0.000721	0.00221	CcSEcCtD
Amoxapine—Myocardial infarction—Prednisone—multiple sclerosis	0.000717	0.0022	CcSEcCtD
Amoxapine—ADRA2A—central nervous system—multiple sclerosis	0.000711	0.00186	CbGeAlD
Amoxapine—Dysgeusia—Triamcinolone—multiple sclerosis	0.000708	0.00217	CcSEcCtD
Amoxapine—Nausea—Cladribine—multiple sclerosis	0.000707	0.00217	CcSEcCtD
Amoxapine—Syncope—Prednisolone—multiple sclerosis	0.000705	0.00216	CcSEcCtD
Amoxapine—Paraesthesia—Mitoxantrone—multiple sclerosis	0.000703	0.00216	CcSEcCtD
Amoxapine—Somnolence—Mitoxantrone—multiple sclerosis	0.000696	0.00213	CcSEcCtD
Amoxapine—ADRA2A—cerebellum—multiple sclerosis	0.000695	0.00182	CbGeAlD
Amoxapine—Loss of consciousness—Prednisolone—multiple sclerosis	0.000691	0.00212	CcSEcCtD
Amoxapine—Dyspepsia—Mitoxantrone—multiple sclerosis	0.000689	0.00211	CcSEcCtD
Amoxapine—Convulsion—Prednisolone—multiple sclerosis	0.000682	0.00209	CcSEcCtD
Amoxapine—Decreased appetite—Mitoxantrone—multiple sclerosis	0.00068	0.00209	CcSEcCtD
Amoxapine—Hypertension—Prednisolone—multiple sclerosis	0.000679	0.00208	CcSEcCtD
Amoxapine—Eosinophilia—Methotrexate—multiple sclerosis	0.000679	0.00208	CcSEcCtD
Amoxapine—Fatigue—Mitoxantrone—multiple sclerosis	0.000675	0.00207	CcSEcCtD
Amoxapine—Pancreatitis—Methotrexate—multiple sclerosis	0.000672	0.00206	CcSEcCtD
Amoxapine—Constipation—Mitoxantrone—multiple sclerosis	0.000669	0.00205	CcSEcCtD
Amoxapine—Alopecia—Betamethasone—multiple sclerosis	0.000666	0.00204	CcSEcCtD
Amoxapine—Alopecia—Dexamethasone—multiple sclerosis	0.000666	0.00204	CcSEcCtD
Amoxapine—Diarrhoea—Azathioprine—multiple sclerosis	0.000662	0.00203	CcSEcCtD
Amoxapine—Hallucination—Prednisone—multiple sclerosis	0.000653	0.002	CcSEcCtD
Amoxapine—Syncope—Triamcinolone—multiple sclerosis	0.000649	0.00199	CcSEcCtD
Amoxapine—Syncope—Methylprednisolone—multiple sclerosis	0.000647	0.00199	CcSEcCtD
Amoxapine—Feeling abnormal—Mitoxantrone—multiple sclerosis	0.000645	0.00198	CcSEcCtD
Amoxapine—Oedema—Prednisolone—multiple sclerosis	0.000642	0.00197	CcSEcCtD
Amoxapine—Dizziness—Azathioprine—multiple sclerosis	0.00064	0.00196	CcSEcCtD
Amoxapine—Gastrointestinal pain—Mitoxantrone—multiple sclerosis	0.00064	0.00196	CcSEcCtD
Amoxapine—Loss of consciousness—Triamcinolone—multiple sclerosis	0.000636	0.00195	CcSEcCtD
Amoxapine—Loss of consciousness—Methylprednisolone—multiple sclerosis	0.000634	0.00195	CcSEcCtD
Amoxapine—Shock—Prednisolone—multiple sclerosis	0.000632	0.00194	CcSEcCtD
Amoxapine—Erectile dysfunction—Methotrexate—multiple sclerosis	0.000631	0.00194	CcSEcCtD
Amoxapine—HTR2A—nervous system—multiple sclerosis	0.000628	0.00165	CbGeAlD
Amoxapine—Convulsion—Triamcinolone—multiple sclerosis	0.000627	0.00192	CcSEcCtD
Amoxapine—Tachycardia—Prednisolone—multiple sclerosis	0.000627	0.00192	CcSEcCtD
Amoxapine—Convulsion—Methylprednisolone—multiple sclerosis	0.000625	0.00192	CcSEcCtD
Amoxapine—Hypertension—Triamcinolone—multiple sclerosis	0.000625	0.00192	CcSEcCtD
Amoxapine—Hypertension—Methylprednisolone—multiple sclerosis	0.000623	0.00191	CcSEcCtD
Amoxapine—Urticaria—Mitoxantrone—multiple sclerosis	0.000622	0.00191	CcSEcCtD
Amoxapine—Body temperature increased—Mitoxantrone—multiple sclerosis	0.000619	0.0019	CcSEcCtD
Amoxapine—Abdominal pain—Mitoxantrone—multiple sclerosis	0.000619	0.0019	CcSEcCtD
Amoxapine—Vomiting—Azathioprine—multiple sclerosis	0.000615	0.00189	CcSEcCtD
Amoxapine—Drowsiness—Methotrexate—multiple sclerosis	0.000611	0.00188	CcSEcCtD
Amoxapine—Rash—Azathioprine—multiple sclerosis	0.00061	0.00187	CcSEcCtD
Amoxapine—Dermatitis—Azathioprine—multiple sclerosis	0.00061	0.00187	CcSEcCtD
Amoxapine—Headache—Azathioprine—multiple sclerosis	0.000606	0.00186	CcSEcCtD
Amoxapine—HTR2A—central nervous system—multiple sclerosis	0.000605	0.00158	CbGeAlD
Amoxapine—Dry mouth—Triamcinolone—multiple sclerosis	0.000602	0.00185	CcSEcCtD
Amoxapine—Stomatitis—Methotrexate—multiple sclerosis	0.000596	0.00183	CcSEcCtD
Amoxapine—Confusional state—Methylprednisolone—multiple sclerosis	0.000594	0.00182	CcSEcCtD
Amoxapine—HTR2A—cerebellum—multiple sclerosis	0.000591	0.00155	CbGeAlD
Amoxapine—Oedema—Triamcinolone—multiple sclerosis	0.00059	0.00181	CcSEcCtD
Amoxapine—Syncope—Betamethasone—multiple sclerosis	0.000589	0.00181	CcSEcCtD
Amoxapine—Syncope—Dexamethasone—multiple sclerosis	0.000589	0.00181	CcSEcCtD
Amoxapine—Shock—Triamcinolone—multiple sclerosis	0.000581	0.00178	CcSEcCtD
Amoxapine—Insomnia—Prednisolone—multiple sclerosis	0.000581	0.00178	CcSEcCtD
Amoxapine—Alopecia—Prednisone—multiple sclerosis	0.00058	0.00178	CcSEcCtD
Amoxapine—Shock—Methylprednisolone—multiple sclerosis	0.00058	0.00178	CcSEcCtD
Amoxapine—Loss of consciousness—Betamethasone—multiple sclerosis	0.000577	0.00177	CcSEcCtD
Amoxapine—Loss of consciousness—Dexamethasone—multiple sclerosis	0.000577	0.00177	CcSEcCtD
Amoxapine—Paraesthesia—Prednisolone—multiple sclerosis	0.000577	0.00177	CcSEcCtD
Amoxapine—Tachycardia—Triamcinolone—multiple sclerosis	0.000576	0.00177	CcSEcCtD
Amoxapine—Nausea—Azathioprine—multiple sclerosis	0.000575	0.00176	CcSEcCtD
Amoxapine—Tachycardia—Methylprednisolone—multiple sclerosis	0.000575	0.00176	CcSEcCtD
Amoxapine—HRH1—brain—multiple sclerosis	0.000575	0.00151	CbGeAlD
Amoxapine—CYP2D6—nervous system—multiple sclerosis	0.000572	0.0015	CbGeAlD
Amoxapine—Agranulocytosis—Methotrexate—multiple sclerosis	0.000571	0.00175	CcSEcCtD
Amoxapine—Convulsion—Dexamethasone—multiple sclerosis	0.000569	0.00175	CcSEcCtD
Amoxapine—Convulsion—Betamethasone—multiple sclerosis	0.000569	0.00175	CcSEcCtD
Amoxapine—Hypertension—Dexamethasone—multiple sclerosis	0.000567	0.00174	CcSEcCtD
Amoxapine—Hypertension—Betamethasone—multiple sclerosis	0.000567	0.00174	CcSEcCtD
Amoxapine—ADRA2A—brain—multiple sclerosis	0.000564	0.00148	CbGeAlD
Amoxapine—Asthenia—Mitoxantrone—multiple sclerosis	0.000561	0.00172	CcSEcCtD
Amoxapine—CYP2D6—central nervous system—multiple sclerosis	0.000551	0.00144	CbGeAlD
Amoxapine—Hypotension—Methylprednisolone—multiple sclerosis	0.00055	0.00169	CcSEcCtD
Amoxapine—Hepatitis—Methotrexate—multiple sclerosis	0.000549	0.00168	CcSEcCtD
Amoxapine—Vision blurred—Prednisone—multiple sclerosis	0.000539	0.00165	CcSEcCtD
Amoxapine—CYP2D6—cerebellum—multiple sclerosis	0.000538	0.00141	CbGeAlD
Amoxapine—Oedema—Dexamethasone—multiple sclerosis	0.000536	0.00164	CcSEcCtD
Amoxapine—Oedema—Betamethasone—multiple sclerosis	0.000536	0.00164	CcSEcCtD
Amoxapine—Diarrhoea—Mitoxantrone—multiple sclerosis	0.000535	0.00164	CcSEcCtD
Amoxapine—Insomnia—Triamcinolone—multiple sclerosis	0.000534	0.00164	CcSEcCtD
Amoxapine—Insomnia—Methylprednisolone—multiple sclerosis	0.000533	0.00163	CcSEcCtD
Amoxapine—Paraesthesia—Triamcinolone—multiple sclerosis	0.00053	0.00163	CcSEcCtD
Amoxapine—Feeling abnormal—Prednisolone—multiple sclerosis	0.000529	0.00162	CcSEcCtD
Amoxapine—Paraesthesia—Methylprednisolone—multiple sclerosis	0.000529	0.00162	CcSEcCtD
Amoxapine—Shock—Dexamethasone—multiple sclerosis	0.000527	0.00162	CcSEcCtD
Amoxapine—Shock—Betamethasone—multiple sclerosis	0.000527	0.00162	CcSEcCtD
Amoxapine—Agitation—Prednisone—multiple sclerosis	0.000525	0.00161	CcSEcCtD
Amoxapine—Thrombocytopenia—Betamethasone—multiple sclerosis	0.000525	0.00161	CcSEcCtD
Amoxapine—Thrombocytopenia—Dexamethasone—multiple sclerosis	0.000525	0.00161	CcSEcCtD
Amoxapine—Tachycardia—Dexamethasone—multiple sclerosis	0.000523	0.0016	CcSEcCtD
Amoxapine—Tachycardia—Betamethasone—multiple sclerosis	0.000523	0.0016	CcSEcCtD
Amoxapine—Dyspepsia—Triamcinolone—multiple sclerosis	0.00052	0.00159	CcSEcCtD
Amoxapine—Dyspepsia—Methylprednisolone—multiple sclerosis	0.000519	0.00159	CcSEcCtD
Amoxapine—Syncope—Prednisone—multiple sclerosis	0.000513	0.00157	CcSEcCtD
Amoxapine—Tinnitus—Methotrexate—multiple sclerosis	0.000512	0.00157	CcSEcCtD
Amoxapine—Anorexia—Dexamethasone—multiple sclerosis	0.000511	0.00157	CcSEcCtD
Amoxapine—Anorexia—Betamethasone—multiple sclerosis	0.000511	0.00157	CcSEcCtD
Amoxapine—Urticaria—Prednisolone—multiple sclerosis	0.00051	0.00157	CcSEcCtD
Amoxapine—Fatigue—Triamcinolone—multiple sclerosis	0.000509	0.00156	CcSEcCtD
Amoxapine—Fatigue—Methylprednisolone—multiple sclerosis	0.000508	0.00156	CcSEcCtD
Amoxapine—Loss of consciousness—Prednisone—multiple sclerosis	0.000502	0.00154	CcSEcCtD
Amoxapine—Hypotension—Betamethasone—multiple sclerosis	0.000501	0.00154	CcSEcCtD
Amoxapine—Hypotension—Dexamethasone—multiple sclerosis	0.000501	0.00154	CcSEcCtD
Amoxapine—Vomiting—Mitoxantrone—multiple sclerosis	0.000498	0.00153	CcSEcCtD
Amoxapine—Convulsion—Prednisone—multiple sclerosis	0.000495	0.00152	CcSEcCtD
Amoxapine—Hypertension—Prednisone—multiple sclerosis	0.000494	0.00151	CcSEcCtD
Amoxapine—Rash—Mitoxantrone—multiple sclerosis	0.000493	0.00151	CcSEcCtD
Amoxapine—Dermatitis—Mitoxantrone—multiple sclerosis	0.000493	0.00151	CcSEcCtD
Amoxapine—Headache—Mitoxantrone—multiple sclerosis	0.00049	0.0015	CcSEcCtD
Amoxapine—Feeling abnormal—Triamcinolone—multiple sclerosis	0.000487	0.00149	CcSEcCtD
Amoxapine—Feeling abnormal—Methylprednisolone—multiple sclerosis	0.000485	0.00149	CcSEcCtD
Amoxapine—Alopecia—Methotrexate—multiple sclerosis	0.000485	0.00149	CcSEcCtD
Amoxapine—Insomnia—Dexamethasone—multiple sclerosis	0.000485	0.00149	CcSEcCtD
Amoxapine—Insomnia—Betamethasone—multiple sclerosis	0.000485	0.00149	CcSEcCtD
Amoxapine—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	0.000482	0.00148	CcSEcCtD
Amoxapine—Paraesthesia—Dexamethasone—multiple sclerosis	0.000481	0.00148	CcSEcCtD
Amoxapine—Paraesthesia—Betamethasone—multiple sclerosis	0.000481	0.00148	CcSEcCtD
Amoxapine—HTR2A—brain—multiple sclerosis	0.00048	0.00126	CbGeAlD
Amoxapine—Dyspepsia—Dexamethasone—multiple sclerosis	0.000472	0.00145	CcSEcCtD
Amoxapine—Dyspepsia—Betamethasone—multiple sclerosis	0.000472	0.00145	CcSEcCtD
Amoxapine—Urticaria—Triamcinolone—multiple sclerosis	0.000469	0.00144	CcSEcCtD
Amoxapine—Urticaria—Methylprednisolone—multiple sclerosis	0.000468	0.00144	CcSEcCtD
Amoxapine—Dysgeusia—Methotrexate—multiple sclerosis	0.000468	0.00144	CcSEcCtD
Amoxapine—Body temperature increased—Triamcinolone—multiple sclerosis	0.000467	0.00143	CcSEcCtD
Amoxapine—Oedema—Prednisone—multiple sclerosis	0.000467	0.00143	CcSEcCtD
Amoxapine—Abdominal pain—Methylprednisolone—multiple sclerosis	0.000466	0.00143	CcSEcCtD
Amoxapine—Decreased appetite—Betamethasone—multiple sclerosis	0.000466	0.00143	CcSEcCtD
Amoxapine—Decreased appetite—Dexamethasone—multiple sclerosis	0.000466	0.00143	CcSEcCtD
Amoxapine—Nausea—Mitoxantrone—multiple sclerosis	0.000465	0.00143	CcSEcCtD
Amoxapine—Fatigue—Betamethasone—multiple sclerosis	0.000462	0.00142	CcSEcCtD
Amoxapine—Fatigue—Dexamethasone—multiple sclerosis	0.000462	0.00142	CcSEcCtD
Amoxapine—Shock—Prednisone—multiple sclerosis	0.000459	0.00141	CcSEcCtD
Amoxapine—Tachycardia—Prednisone—multiple sclerosis	0.000455	0.0014	CcSEcCtD
Amoxapine—Vision blurred—Methotrexate—multiple sclerosis	0.00045	0.00138	CcSEcCtD
Amoxapine—Anorexia—Prednisone—multiple sclerosis	0.000445	0.00136	CcSEcCtD
Amoxapine—Feeling abnormal—Dexamethasone—multiple sclerosis	0.000441	0.00135	CcSEcCtD
Amoxapine—Feeling abnormal—Betamethasone—multiple sclerosis	0.000441	0.00135	CcSEcCtD
Amoxapine—Gastrointestinal pain—Betamethasone—multiple sclerosis	0.000438	0.00134	CcSEcCtD
Amoxapine—Gastrointestinal pain—Dexamethasone—multiple sclerosis	0.000438	0.00134	CcSEcCtD
Amoxapine—CYP2D6—brain—multiple sclerosis	0.000437	0.00115	CbGeAlD
Amoxapine—Leukopenia—Methotrexate—multiple sclerosis	0.000428	0.00131	CcSEcCtD
Amoxapine—Urticaria—Betamethasone—multiple sclerosis	0.000426	0.00131	CcSEcCtD
Amoxapine—Urticaria—Dexamethasone—multiple sclerosis	0.000426	0.00131	CcSEcCtD
Amoxapine—Dizziness—Prednisolone—multiple sclerosis	0.000425	0.0013	CcSEcCtD
Amoxapine—Asthenia—Triamcinolone—multiple sclerosis	0.000424	0.0013	CcSEcCtD
Amoxapine—Body temperature increased—Dexamethasone—multiple sclerosis	0.000423	0.0013	CcSEcCtD
Amoxapine—Abdominal pain—Betamethasone—multiple sclerosis	0.000423	0.0013	CcSEcCtD
Amoxapine—Abdominal pain—Dexamethasone—multiple sclerosis	0.000423	0.0013	CcSEcCtD
Amoxapine—Body temperature increased—Betamethasone—multiple sclerosis	0.000423	0.0013	CcSEcCtD
Amoxapine—Asthenia—Methylprednisolone—multiple sclerosis	0.000423	0.0013	CcSEcCtD
Amoxapine—Insomnia—Prednisone—multiple sclerosis	0.000422	0.00129	CcSEcCtD
Amoxapine—Paraesthesia—Prednisone—multiple sclerosis	0.000419	0.00129	CcSEcCtD
Amoxapine—Pruritus—Triamcinolone—multiple sclerosis	0.000418	0.00128	CcSEcCtD
Amoxapine—Pruritus—Methylprednisolone—multiple sclerosis	0.000417	0.00128	CcSEcCtD
Amoxapine—Convulsion—Methotrexate—multiple sclerosis	0.000414	0.00127	CcSEcCtD
Amoxapine—Dyspepsia—Prednisone—multiple sclerosis	0.000411	0.00126	CcSEcCtD
Amoxapine—Decreased appetite—Prednisone—multiple sclerosis	0.000406	0.00124	CcSEcCtD
Amoxapine—Rash—Prednisolone—multiple sclerosis	0.000405	0.00124	CcSEcCtD
Amoxapine—Dermatitis—Prednisolone—multiple sclerosis	0.000404	0.00124	CcSEcCtD
Amoxapine—Diarrhoea—Methylprednisolone—multiple sclerosis	0.000403	0.00124	CcSEcCtD
Amoxapine—Fatigue—Prednisone—multiple sclerosis	0.000402	0.00123	CcSEcCtD
Amoxapine—Headache—Prednisolone—multiple sclerosis	0.000402	0.00123	CcSEcCtD
Amoxapine—Constipation—Prednisone—multiple sclerosis	0.000399	0.00122	CcSEcCtD
Amoxapine—Confusional state—Methotrexate—multiple sclerosis	0.000393	0.00121	CcSEcCtD
Amoxapine—Dizziness—Triamcinolone—multiple sclerosis	0.00039	0.0012	CcSEcCtD
Amoxapine—Dizziness—Methylprednisolone—multiple sclerosis	0.00039	0.0012	CcSEcCtD
Amoxapine—Feeling abnormal—Prednisone—multiple sclerosis	0.000384	0.00118	CcSEcCtD
Amoxapine—Asthenia—Dexamethasone—multiple sclerosis	0.000384	0.00118	CcSEcCtD
Amoxapine—Asthenia—Betamethasone—multiple sclerosis	0.000384	0.00118	CcSEcCtD
Amoxapine—Thrombocytopenia—Methotrexate—multiple sclerosis	0.000382	0.00117	CcSEcCtD
Amoxapine—Gastrointestinal pain—Prednisone—multiple sclerosis	0.000381	0.00117	CcSEcCtD
Amoxapine—Nausea—Prednisolone—multiple sclerosis	0.000381	0.00117	CcSEcCtD
Amoxapine—Pruritus—Dexamethasone—multiple sclerosis	0.000379	0.00116	CcSEcCtD
Amoxapine—Pruritus—Betamethasone—multiple sclerosis	0.000379	0.00116	CcSEcCtD
Amoxapine—Vomiting—Triamcinolone—multiple sclerosis	0.000375	0.00115	CcSEcCtD
Amoxapine—Vomiting—Methylprednisolone—multiple sclerosis	0.000375	0.00115	CcSEcCtD
Amoxapine—Rash—Triamcinolone—multiple sclerosis	0.000372	0.00114	CcSEcCtD
Amoxapine—Dermatitis—Triamcinolone—multiple sclerosis	0.000372	0.00114	CcSEcCtD
Amoxapine—Anorexia—Methotrexate—multiple sclerosis	0.000372	0.00114	CcSEcCtD
Amoxapine—Rash—Methylprednisolone—multiple sclerosis	0.000371	0.00114	CcSEcCtD
Amoxapine—Dermatitis—Methylprednisolone—multiple sclerosis	0.000371	0.00114	CcSEcCtD
Amoxapine—Urticaria—Prednisone—multiple sclerosis	0.000371	0.00114	CcSEcCtD
Amoxapine—Headache—Triamcinolone—multiple sclerosis	0.00037	0.00113	CcSEcCtD
Amoxapine—Headache—Methylprednisolone—multiple sclerosis	0.000369	0.00113	CcSEcCtD
Amoxapine—Abdominal pain—Prednisone—multiple sclerosis	0.000369	0.00113	CcSEcCtD
Amoxapine—Body temperature increased—Prednisone—multiple sclerosis	0.000369	0.00113	CcSEcCtD
Amoxapine—Diarrhoea—Dexamethasone—multiple sclerosis	0.000367	0.00112	CcSEcCtD
Amoxapine—Diarrhoea—Betamethasone—multiple sclerosis	0.000367	0.00112	CcSEcCtD
Amoxapine—Hypotension—Methotrexate—multiple sclerosis	0.000364	0.00112	CcSEcCtD
Amoxapine—Dizziness—Betamethasone—multiple sclerosis	0.000354	0.00109	CcSEcCtD
Amoxapine—Dizziness—Dexamethasone—multiple sclerosis	0.000354	0.00109	CcSEcCtD
Amoxapine—Insomnia—Methotrexate—multiple sclerosis	0.000353	0.00108	CcSEcCtD
Amoxapine—Nausea—Triamcinolone—multiple sclerosis	0.000351	0.00108	CcSEcCtD
Amoxapine—Paraesthesia—Methotrexate—multiple sclerosis	0.00035	0.00107	CcSEcCtD
Amoxapine—Nausea—Methylprednisolone—multiple sclerosis	0.00035	0.00107	CcSEcCtD
Amoxapine—Somnolence—Methotrexate—multiple sclerosis	0.000347	0.00106	CcSEcCtD
Amoxapine—Dyspepsia—Methotrexate—multiple sclerosis	0.000343	0.00105	CcSEcCtD
Amoxapine—Vomiting—Dexamethasone—multiple sclerosis	0.000341	0.00105	CcSEcCtD
Amoxapine—Vomiting—Betamethasone—multiple sclerosis	0.000341	0.00105	CcSEcCtD
Amoxapine—Decreased appetite—Methotrexate—multiple sclerosis	0.000339	0.00104	CcSEcCtD
Amoxapine—Rash—Betamethasone—multiple sclerosis	0.000338	0.00104	CcSEcCtD
Amoxapine—Rash—Dexamethasone—multiple sclerosis	0.000338	0.00104	CcSEcCtD
Amoxapine—Dermatitis—Dexamethasone—multiple sclerosis	0.000337	0.00104	CcSEcCtD
Amoxapine—Dermatitis—Betamethasone—multiple sclerosis	0.000337	0.00104	CcSEcCtD
Amoxapine—Fatigue—Methotrexate—multiple sclerosis	0.000336	0.00103	CcSEcCtD
Amoxapine—Headache—Betamethasone—multiple sclerosis	0.000336	0.00103	CcSEcCtD
Amoxapine—Headache—Dexamethasone—multiple sclerosis	0.000336	0.00103	CcSEcCtD
Amoxapine—Asthenia—Prednisone—multiple sclerosis	0.000335	0.00103	CcSEcCtD
Amoxapine—Pruritus—Prednisone—multiple sclerosis	0.00033	0.00101	CcSEcCtD
Amoxapine—Feeling abnormal—Methotrexate—multiple sclerosis	0.000321	0.000986	CcSEcCtD
Amoxapine—Diarrhoea—Prednisone—multiple sclerosis	0.000319	0.000979	CcSEcCtD
Amoxapine—Gastrointestinal pain—Methotrexate—multiple sclerosis	0.000319	0.000978	CcSEcCtD
Amoxapine—Nausea—Betamethasone—multiple sclerosis	0.000318	0.000976	CcSEcCtD
Amoxapine—Nausea—Dexamethasone—multiple sclerosis	0.000318	0.000976	CcSEcCtD
Amoxapine—Urticaria—Methotrexate—multiple sclerosis	0.00031	0.00095	CcSEcCtD
Amoxapine—Dizziness—Prednisone—multiple sclerosis	0.000309	0.000947	CcSEcCtD
Amoxapine—Abdominal pain—Methotrexate—multiple sclerosis	0.000308	0.000946	CcSEcCtD
Amoxapine—Body temperature increased—Methotrexate—multiple sclerosis	0.000308	0.000946	CcSEcCtD
Amoxapine—Vomiting—Prednisone—multiple sclerosis	0.000297	0.00091	CcSEcCtD
Amoxapine—Rash—Prednisone—multiple sclerosis	0.000294	0.000903	CcSEcCtD
Amoxapine—Dermatitis—Prednisone—multiple sclerosis	0.000294	0.000902	CcSEcCtD
Amoxapine—Headache—Prednisone—multiple sclerosis	0.000292	0.000897	CcSEcCtD
Amoxapine—Asthenia—Methotrexate—multiple sclerosis	0.00028	0.000858	CcSEcCtD
Amoxapine—Nausea—Prednisone—multiple sclerosis	0.000277	0.00085	CcSEcCtD
Amoxapine—Pruritus—Methotrexate—multiple sclerosis	0.000276	0.000846	CcSEcCtD
Amoxapine—Diarrhoea—Methotrexate—multiple sclerosis	0.000267	0.000819	CcSEcCtD
Amoxapine—Dizziness—Methotrexate—multiple sclerosis	0.000258	0.000791	CcSEcCtD
Amoxapine—Vomiting—Methotrexate—multiple sclerosis	0.000248	0.000761	CcSEcCtD
Amoxapine—Rash—Methotrexate—multiple sclerosis	0.000246	0.000754	CcSEcCtD
Amoxapine—Dermatitis—Methotrexate—multiple sclerosis	0.000246	0.000754	CcSEcCtD
Amoxapine—Headache—Methotrexate—multiple sclerosis	0.000244	0.000749	CcSEcCtD
Amoxapine—Nausea—Methotrexate—multiple sclerosis	0.000232	0.000711	CcSEcCtD
Amoxapine—DRD4—Signaling Pathways—POMC—multiple sclerosis	2.64e-05	9.03e-05	CbGpPWpGaD
Amoxapine—HRH4—Signaling Pathways—MAPK1—multiple sclerosis	2.63e-05	8.98e-05	CbGpPWpGaD
Amoxapine—HTR1B—Signaling Pathways—CCL2—multiple sclerosis	2.63e-05	8.98e-05	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—CCR5—multiple sclerosis	2.62e-05	8.94e-05	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—CCR5—multiple sclerosis	2.6e-05	8.9e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling by GPCR—TYK2—multiple sclerosis	2.6e-05	8.89e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—CD86—multiple sclerosis	2.59e-05	8.85e-05	CbGpPWpGaD
Amoxapine—DRD4—Signaling Pathways—CCL2—multiple sclerosis	2.58e-05	8.84e-05	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—IL2RA—multiple sclerosis	2.58e-05	8.82e-05	CbGpPWpGaD
Amoxapine—HTR1B—Signaling by GPCR—MAPK1—multiple sclerosis	2.57e-05	8.78e-05	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—IL2RA—multiple sclerosis	2.57e-05	8.77e-05	CbGpPWpGaD
Amoxapine—HTR1A—Signaling by GPCR—IL2—multiple sclerosis	2.56e-05	8.75e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—CCL5—multiple sclerosis	2.55e-05	8.72e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—CD86—multiple sclerosis	2.55e-05	8.71e-05	CbGpPWpGaD
Amoxapine—HTR2C—Signaling by GPCR—IL2—multiple sclerosis	2.55e-05	8.7e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—CD86—multiple sclerosis	2.54e-05	8.69e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—CD86—multiple sclerosis	2.53e-05	8.67e-05	CbGpPWpGaD
Amoxapine—DRD4—Signaling by GPCR—MAPK1—multiple sclerosis	2.53e-05	8.64e-05	CbGpPWpGaD
Amoxapine—HTR2B—Signaling Pathways—POMC—multiple sclerosis	2.52e-05	8.62e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—CCL5—multiple sclerosis	2.51e-05	8.58e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—CCL5—multiple sclerosis	2.5e-05	8.56e-05	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—CD80—multiple sclerosis	2.5e-05	8.56e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—CCL5—multiple sclerosis	2.5e-05	8.53e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—CD86—multiple sclerosis	2.5e-05	8.53e-05	CbGpPWpGaD
Amoxapine—DRD2—GPCR downstream signaling—IL2—multiple sclerosis	2.47e-05	8.46e-05	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—CD80—multiple sclerosis	2.47e-05	8.44e-05	CbGpPWpGaD
Amoxapine—HTR2B—Signaling Pathways—CCL2—multiple sclerosis	2.47e-05	8.43e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—CCL5—multiple sclerosis	2.46e-05	8.4e-05	CbGpPWpGaD
Amoxapine—HTR6—Signaling Pathways—TYK2—multiple sclerosis	2.45e-05	8.39e-05	CbGpPWpGaD
Amoxapine—HTR7—Signaling Pathways—TYK2—multiple sclerosis	2.45e-05	8.38e-05	CbGpPWpGaD
Amoxapine—HTR2A—GPCR downstream signaling—IL2—multiple sclerosis	2.43e-05	8.32e-05	CbGpPWpGaD
Amoxapine—HRH1—GPCR downstream signaling—IL2—multiple sclerosis	2.43e-05	8.3e-05	CbGpPWpGaD
Amoxapine—CYP2D6—Metabolism—BCHE—multiple sclerosis	2.42e-05	8.28e-05	CbGpPWpGaD
Amoxapine—CHRM1—GPCR downstream signaling—IL2—multiple sclerosis	2.42e-05	8.28e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling by GPCR—TYK2—multiple sclerosis	2.42e-05	8.26e-05	CbGpPWpGaD
Amoxapine—HTR2B—Signaling by GPCR—MAPK1—multiple sclerosis	2.41e-05	8.25e-05	CbGpPWpGaD
Amoxapine—HTR1B—Signaling Pathways—TYK2—multiple sclerosis	2.38e-05	8.15e-05	CbGpPWpGaD
Amoxapine—ADRA1A—GPCR downstream signaling—IL2—multiple sclerosis	2.38e-05	8.15e-05	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—APOE—multiple sclerosis	2.38e-05	8.14e-05	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—POMC—multiple sclerosis	2.38e-05	8.13e-05	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—APOE—multiple sclerosis	2.37e-05	8.1e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—SPP1—multiple sclerosis	2.36e-05	8.07e-05	CbGpPWpGaD
Amoxapine—DRD4—Signaling Pathways—TYK2—multiple sclerosis	2.35e-05	8.02e-05	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—POMC—multiple sclerosis	2.35e-05	8.02e-05	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—CCL2—multiple sclerosis	2.33e-05	7.95e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—SPP1—multiple sclerosis	2.32e-05	7.94e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—CD86—multiple sclerosis	2.32e-05	7.93e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—SPP1—multiple sclerosis	2.32e-05	7.93e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—SPP1—multiple sclerosis	2.31e-05	7.9e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—CCR5—multiple sclerosis	2.3e-05	7.85e-05	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—CCL2—multiple sclerosis	2.3e-05	7.85e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—CCL5—multiple sclerosis	2.28e-05	7.8e-05	CbGpPWpGaD
Amoxapine—DRD1—Signaling by GPCR—MAPK1—multiple sclerosis	2.28e-05	7.78e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—SPP1—multiple sclerosis	2.28e-05	7.78e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—IL2RA—multiple sclerosis	2.26e-05	7.74e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—CCR5—multiple sclerosis	2.26e-05	7.73e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—CCR5—multiple sclerosis	2.26e-05	7.71e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—CCR5—multiple sclerosis	2.25e-05	7.69e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling by GPCR—IL2—multiple sclerosis	2.25e-05	7.68e-05	CbGpPWpGaD
Amoxapine—DRD3—Signaling by GPCR—MAPK1—multiple sclerosis	2.25e-05	7.68e-05	CbGpPWpGaD
Amoxapine—HTR2B—Signaling Pathways—TYK2—multiple sclerosis	2.24e-05	7.66e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Metabolism—APOE—multiple sclerosis	2.24e-05	7.65e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—IL2RA—multiple sclerosis	2.23e-05	7.62e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—IL2RA—multiple sclerosis	2.22e-05	7.6e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—IL2RA—multiple sclerosis	2.22e-05	7.57e-05	CbGpPWpGaD
Amoxapine—ADRA2A—GPCR downstream signaling—IL2—multiple sclerosis	2.21e-05	7.57e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—CCR5—multiple sclerosis	2.21e-05	7.57e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling by GPCR—IL2—multiple sclerosis	2.21e-05	7.56e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling by GPCR—IL2—multiple sclerosis	2.21e-05	7.54e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling by GPCR—IL2—multiple sclerosis	2.2e-05	7.52e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—IL2RA—multiple sclerosis	2.18e-05	7.46e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling by GPCR—IL2—multiple sclerosis	2.16e-05	7.4e-05	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—CD80—multiple sclerosis	2.15e-05	7.36e-05	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—CD80—multiple sclerosis	2.14e-05	7.32e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—SPP1—multiple sclerosis	2.11e-05	7.23e-05	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—TYK2—multiple sclerosis	2.11e-05	7.22e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—APOE—multiple sclerosis	2.09e-05	7.14e-05	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—TYK2—multiple sclerosis	2.08e-05	7.13e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—APOE—multiple sclerosis	2.06e-05	7.03e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—CCR5—multiple sclerosis	2.06e-05	7.03e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—APOE—multiple sclerosis	2.05e-05	7.01e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—APOE—multiple sclerosis	2.05e-05	6.99e-05	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—POMC—multiple sclerosis	2.04e-05	6.99e-05	CbGpPWpGaD
Amoxapine—HTR6—Signaling Pathways—IL2—multiple sclerosis	2.04e-05	6.98e-05	CbGpPWpGaD
Amoxapine—HTR7—Signaling Pathways—IL2—multiple sclerosis	2.04e-05	6.97e-05	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—POMC—multiple sclerosis	2.03e-05	6.95e-05	CbGpPWpGaD
Amoxapine—HTR6—Signaling by GPCR—IL6—multiple sclerosis	2.03e-05	6.95e-05	CbGpPWpGaD
Amoxapine—HTR7—Signaling by GPCR—IL6—multiple sclerosis	2.03e-05	6.94e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—IL2RA—multiple sclerosis	2.03e-05	6.93e-05	CbGpPWpGaD
Amoxapine—HRH4—Signaling Pathways—IL6—multiple sclerosis	2.02e-05	6.9e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—APOE—multiple sclerosis	2.01e-05	6.88e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling by GPCR—IL2—multiple sclerosis	2.01e-05	6.88e-05	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—CCL2—multiple sclerosis	2e-05	6.84e-05	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—CCL2—multiple sclerosis	1.99e-05	6.8e-05	CbGpPWpGaD
Amoxapine—HTR1B—Signaling Pathways—IL2—multiple sclerosis	1.98e-05	6.78e-05	CbGpPWpGaD
Amoxapine—HTR1B—Signaling by GPCR—IL6—multiple sclerosis	1.97e-05	6.75e-05	CbGpPWpGaD
Amoxapine—HTR1A—Signaling by GPCR—MAPK1—multiple sclerosis	1.96e-05	6.69e-05	CbGpPWpGaD
Amoxapine—DRD4—Signaling Pathways—IL2—multiple sclerosis	1.95e-05	6.68e-05	CbGpPWpGaD
Amoxapine—HTR2C—Signaling by GPCR—MAPK1—multiple sclerosis	1.95e-05	6.66e-05	CbGpPWpGaD
Amoxapine—DRD4—Signaling by GPCR—IL6—multiple sclerosis	1.94e-05	6.64e-05	CbGpPWpGaD
Amoxapine—HTR6—Signaling Pathways—MMP9—multiple sclerosis	1.93e-05	6.61e-05	CbGpPWpGaD
Amoxapine—HTR7—Signaling Pathways—MMP9—multiple sclerosis	1.93e-05	6.6e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Metabolism—POMC—multiple sclerosis	1.92e-05	6.57e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—CD80—multiple sclerosis	1.89e-05	6.46e-05	CbGpPWpGaD
Amoxapine—HTR1B—Signaling Pathways—MMP9—multiple sclerosis	1.88e-05	6.42e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—APOE—multiple sclerosis	1.87e-05	6.4e-05	CbGpPWpGaD
Amoxapine—HTR2B—Signaling Pathways—IL2—multiple sclerosis	1.86e-05	6.37e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—CD80—multiple sclerosis	1.86e-05	6.36e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—CD80—multiple sclerosis	1.86e-05	6.34e-05	CbGpPWpGaD
Amoxapine—HTR2B—Signaling by GPCR—IL6—multiple sclerosis	1.85e-05	6.34e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—CD80—multiple sclerosis	1.85e-05	6.32e-05	CbGpPWpGaD
Amoxapine—DRD4—Signaling Pathways—MMP9—multiple sclerosis	1.85e-05	6.32e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—CD80—multiple sclerosis	1.82e-05	6.22e-05	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—TYK2—multiple sclerosis	1.82e-05	6.21e-05	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—TYK2—multiple sclerosis	1.81e-05	6.18e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—POMC—multiple sclerosis	1.8e-05	6.14e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—POMC—multiple sclerosis	1.77e-05	6.04e-05	CbGpPWpGaD
Amoxapine—HTR2B—Signaling Pathways—MMP9—multiple sclerosis	1.76e-05	6.03e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—POMC—multiple sclerosis	1.76e-05	6.03e-05	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—IL2—multiple sclerosis	1.76e-05	6.01e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—POMC—multiple sclerosis	1.76e-05	6.01e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—CCL2—multiple sclerosis	1.76e-05	6.01e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Metabolism—ALB—multiple sclerosis	1.75e-05	5.99e-05	CbGpPWpGaD
Amoxapine—DRD1—Signaling by GPCR—IL6—multiple sclerosis	1.75e-05	5.98e-05	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—IL2—multiple sclerosis	1.73e-05	5.93e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—POMC—multiple sclerosis	1.73e-05	5.91e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—CCL2—multiple sclerosis	1.73e-05	5.91e-05	CbGpPWpGaD
Amoxapine—DRD3—Signaling by GPCR—IL6—multiple sclerosis	1.73e-05	5.9e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—CCL2—multiple sclerosis	1.72e-05	5.9e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—CCL2—multiple sclerosis	1.72e-05	5.88e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling by GPCR—MAPK1—multiple sclerosis	1.72e-05	5.88e-05	CbGpPWpGaD
Amoxapine—HTR6—Signaling Pathways—STAT3—multiple sclerosis	1.72e-05	5.87e-05	CbGpPWpGaD
Amoxapine—HTR7—Signaling Pathways—STAT3—multiple sclerosis	1.72e-05	5.87e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—CCL2—multiple sclerosis	1.69e-05	5.79e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—CD80—multiple sclerosis	1.69e-05	5.78e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling by GPCR—MAPK1—multiple sclerosis	1.69e-05	5.78e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling by GPCR—MAPK1—multiple sclerosis	1.69e-05	5.77e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling by GPCR—MAPK1—multiple sclerosis	1.68e-05	5.75e-05	CbGpPWpGaD
Amoxapine—HTR1B—Signaling Pathways—STAT3—multiple sclerosis	1.67e-05	5.71e-05	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—MMP9—multiple sclerosis	1.66e-05	5.69e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling by GPCR—MAPK1—multiple sclerosis	1.66e-05	5.66e-05	CbGpPWpGaD
Amoxapine—DRD4—Signaling Pathways—STAT3—multiple sclerosis	1.64e-05	5.62e-05	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—MMP9—multiple sclerosis	1.64e-05	5.61e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—POMC—multiple sclerosis	1.61e-05	5.49e-05	CbGpPWpGaD
Amoxapine—HTR6—Signaling Pathways—MYC—multiple sclerosis	1.6e-05	5.46e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—TYK2—multiple sclerosis	1.6e-05	5.45e-05	CbGpPWpGaD
Amoxapine—HTR7—Signaling Pathways—MYC—multiple sclerosis	1.6e-05	5.45e-05	CbGpPWpGaD
Amoxapine—HTR6—Signaling Pathways—TGFB1—multiple sclerosis	1.59e-05	5.45e-05	CbGpPWpGaD
Amoxapine—HTR7—Signaling Pathways—TGFB1—multiple sclerosis	1.59e-05	5.44e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—CCL2—multiple sclerosis	1.57e-05	5.38e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—TYK2—multiple sclerosis	1.57e-05	5.37e-05	CbGpPWpGaD
Amoxapine—HTR2B—Signaling Pathways—STAT3—multiple sclerosis	1.57e-05	5.36e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—TYK2—multiple sclerosis	1.57e-05	5.35e-05	CbGpPWpGaD
Amoxapine—HTR6—Signaling Pathways—MAPK1—multiple sclerosis	1.56e-05	5.34e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—TYK2—multiple sclerosis	1.56e-05	5.34e-05	CbGpPWpGaD
Amoxapine—HTR7—Signaling Pathways—MAPK1—multiple sclerosis	1.56e-05	5.33e-05	CbGpPWpGaD
Amoxapine—HTR1B—Signaling Pathways—MYC—multiple sclerosis	1.55e-05	5.3e-05	CbGpPWpGaD
Amoxapine—HTR1B—Signaling Pathways—TGFB1—multiple sclerosis	1.55e-05	5.29e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling by GPCR—MAPK1—multiple sclerosis	1.54e-05	5.26e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—TYK2—multiple sclerosis	1.54e-05	5.25e-05	CbGpPWpGaD
Amoxapine—DRD4—Signaling Pathways—MYC—multiple sclerosis	1.53e-05	5.22e-05	CbGpPWpGaD
Amoxapine—DRD4—Signaling Pathways—TGFB1—multiple sclerosis	1.52e-05	5.21e-05	CbGpPWpGaD
Amoxapine—HTR1B—Signaling Pathways—MAPK1—multiple sclerosis	1.52e-05	5.19e-05	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—IL2—multiple sclerosis	1.51e-05	5.17e-05	CbGpPWpGaD
Amoxapine—HTR1A—Signaling by GPCR—IL6—multiple sclerosis	1.5e-05	5.14e-05	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—IL2—multiple sclerosis	1.5e-05	5.14e-05	CbGpPWpGaD
Amoxapine—HTR2C—Signaling by GPCR—IL6—multiple sclerosis	1.5e-05	5.12e-05	CbGpPWpGaD
Amoxapine—DRD4—Signaling Pathways—MAPK1—multiple sclerosis	1.49e-05	5.11e-05	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—STAT3—multiple sclerosis	1.48e-05	5.06e-05	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—STAT3—multiple sclerosis	1.46e-05	4.99e-05	CbGpPWpGaD
Amoxapine—CYP2D6—Metabolism—APOE—multiple sclerosis	1.46e-05	4.98e-05	CbGpPWpGaD
Amoxapine—HTR2B—Signaling Pathways—MYC—multiple sclerosis	1.46e-05	4.98e-05	CbGpPWpGaD
Amoxapine—HTR2B—Signaling Pathways—TGFB1—multiple sclerosis	1.45e-05	4.97e-05	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—MMP9—multiple sclerosis	1.43e-05	4.89e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—TYK2—multiple sclerosis	1.43e-05	4.88e-05	CbGpPWpGaD
Amoxapine—HTR2B—Signaling Pathways—MAPK1—multiple sclerosis	1.43e-05	4.87e-05	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—MMP9—multiple sclerosis	1.42e-05	4.87e-05	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—MYC—multiple sclerosis	1.37e-05	4.7e-05	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—TGFB1—multiple sclerosis	1.37e-05	4.69e-05	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—MYC—multiple sclerosis	1.36e-05	4.64e-05	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—TGFB1—multiple sclerosis	1.35e-05	4.63e-05	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—MAPK1—multiple sclerosis	1.34e-05	4.6e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—IL2—multiple sclerosis	1.33e-05	4.54e-05	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—MAPK1—multiple sclerosis	1.33e-05	4.54e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling by GPCR—IL6—multiple sclerosis	1.32e-05	4.51e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—IL2—multiple sclerosis	1.31e-05	4.46e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—IL2—multiple sclerosis	1.3e-05	4.45e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling by GPCR—IL6—multiple sclerosis	1.3e-05	4.44e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—IL2—multiple sclerosis	1.3e-05	4.44e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling by GPCR—IL6—multiple sclerosis	1.3e-05	4.43e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling by GPCR—IL6—multiple sclerosis	1.29e-05	4.42e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—IL2—multiple sclerosis	1.28e-05	4.37e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling by GPCR—IL6—multiple sclerosis	1.27e-05	4.35e-05	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—STAT3—multiple sclerosis	1.27e-05	4.35e-05	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—STAT3—multiple sclerosis	1.27e-05	4.33e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—MMP9—multiple sclerosis	1.26e-05	4.29e-05	CbGpPWpGaD
Amoxapine—CYP2D6—Metabolism—POMC—multiple sclerosis	1.25e-05	4.28e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—MMP9—multiple sclerosis	1.24e-05	4.23e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—MMP9—multiple sclerosis	1.23e-05	4.22e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—MMP9—multiple sclerosis	1.23e-05	4.2e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—MMP9—multiple sclerosis	1.21e-05	4.14e-05	CbGpPWpGaD
Amoxapine—HTR6—Signaling Pathways—IL6—multiple sclerosis	1.2e-05	4.1e-05	CbGpPWpGaD
Amoxapine—HTR7—Signaling Pathways—IL6—multiple sclerosis	1.2e-05	4.1e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—IL2—multiple sclerosis	1.19e-05	4.06e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling by GPCR—IL6—multiple sclerosis	1.18e-05	4.04e-05	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—MYC—multiple sclerosis	1.18e-05	4.04e-05	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—TGFB1—multiple sclerosis	1.18e-05	4.03e-05	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—MYC—multiple sclerosis	1.18e-05	4.02e-05	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—TGFB1—multiple sclerosis	1.17e-05	4.01e-05	CbGpPWpGaD
Amoxapine—HTR1B—Signaling Pathways—IL6—multiple sclerosis	1.17e-05	3.99e-05	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—MAPK1—multiple sclerosis	1.16e-05	3.95e-05	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—MAPK1—multiple sclerosis	1.15e-05	3.93e-05	CbGpPWpGaD
Amoxapine—DRD4—Signaling Pathways—IL6—multiple sclerosis	1.15e-05	3.92e-05	CbGpPWpGaD
Amoxapine—CYP2D6—Metabolism—ALB—multiple sclerosis	1.14e-05	3.9e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—MMP9—multiple sclerosis	1.12e-05	3.84e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—STAT3—multiple sclerosis	1.12e-05	3.82e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—STAT3—multiple sclerosis	1.1e-05	3.76e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—STAT3—multiple sclerosis	1.1e-05	3.75e-05	CbGpPWpGaD
Amoxapine—HTR2B—Signaling Pathways—IL6—multiple sclerosis	1.1e-05	3.75e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—STAT3—multiple sclerosis	1.09e-05	3.74e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—STAT3—multiple sclerosis	1.08e-05	3.68e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—MYC—multiple sclerosis	1.04e-05	3.55e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—TGFB1—multiple sclerosis	1.04e-05	3.54e-05	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—IL6—multiple sclerosis	1.03e-05	3.53e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—MYC—multiple sclerosis	1.02e-05	3.49e-05	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—IL6—multiple sclerosis	1.02e-05	3.49e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—MYC—multiple sclerosis	1.02e-05	3.48e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—TGFB1—multiple sclerosis	1.02e-05	3.48e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—TGFB1—multiple sclerosis	1.02e-05	3.48e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—MYC—multiple sclerosis	1.02e-05	3.47e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—MAPK1—multiple sclerosis	1.02e-05	3.47e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—TGFB1—multiple sclerosis	1.01e-05	3.46e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—MYC—multiple sclerosis	1e-05	3.42e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—STAT3—multiple sclerosis	1e-05	3.42e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—MAPK1—multiple sclerosis	9.99e-06	3.42e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—TGFB1—multiple sclerosis	9.97e-06	3.41e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—MAPK1—multiple sclerosis	9.97e-06	3.41e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—MAPK1—multiple sclerosis	9.94e-06	3.4e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—MAPK1—multiple sclerosis	9.78e-06	3.34e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—MYC—multiple sclerosis	9.29e-06	3.18e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—TGFB1—multiple sclerosis	9.27e-06	3.17e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—MAPK1—multiple sclerosis	9.09e-06	3.11e-05	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—IL6—multiple sclerosis	8.89e-06	3.04e-05	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—IL6—multiple sclerosis	8.84e-06	3.02e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—IL6—multiple sclerosis	7.8e-06	2.67e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—IL6—multiple sclerosis	7.68e-06	2.62e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—IL6—multiple sclerosis	7.66e-06	2.62e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—IL6—multiple sclerosis	7.64e-06	2.61e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—IL6—multiple sclerosis	7.52e-06	2.57e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—IL6—multiple sclerosis	6.98e-06	2.39e-05	CbGpPWpGaD
